Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.222ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.222ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.222NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.434ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.434ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.434ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.434NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.467ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.467ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.467ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.467NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.110.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.110.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.110.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.23 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.23 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.9 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.9 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.9 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.9 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.74 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.74 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.74 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.74 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.621.1 (Mu)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.621.1 (Mu)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.621.1 (Mu)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.621.1 (Mu)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.7.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.67ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BQ.1.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
CK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used